Applied BioCode (TPE:6598) Beta: -0.4025 (As of Jun. 26, 2026)


TPE:6598 Applied BioCode Corp TPE:6598
74 GF Score
Price NT$22.90
GF Value NT$23.33
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Applied BioCode Beta?

Applied BioCode TPE:6598 -1.29% 74 Beta is -0.4025 as of Jun. 26, 2026. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$23.33 (Fairly Valued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Applied BioCode's Beta is -0.4025.


Applied BioCode  (TPE:6598) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Applied BioCode Beta Related Terms


Applied BioCode Beta Historical Data

* Premium members only.

The historical data trend for Applied BioCode's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied BioCode Beta Chart

Applied BioCode Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.52 1.26 0.67 0.89 0.00

Applied BioCode Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.89 0.00 0.00 0.00 0.00

TPE:6598 vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Applied BioCode's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied BioCode Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Beta distribution charts can be found below:

* The bar in red indicates where Applied BioCode's Beta falls into.


TPE:6598
74GF Score
Applied BioCode Corp TPE:6598
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied BioCode Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.4025 mean?
Applied BioCode (TPE:6598) has a Beta of -0.4025 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Applied BioCode and its competitors.
Is Applied BioCode's Beta too high?
Applied BioCode's current Beta is -0.4025. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's Beta compare to ABT and SYK?
Applied BioCode's Beta of -0.4025 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Applied BioCode and its competitors. Applied BioCode's current Beta is -0.4025. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Fairly Valued. The stock's GF Value™ is NT$23.33, compared to a current price of NT$22.90 — trading 1.8% below its estimated fair value. The current Beta is -0.4025. Applied BioCode's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current Beta is -0.4025 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be undervalued. The current stock price of NT$22.90 is trading 1.8% below its estimated GF Value™ of NT$23.33. GuruFocus considers Applied BioCode to be Fairly Valued.

Key valuation signals for TPE:6598:

  • Beta: -0.4025
  • GF Value™: NT$23.33 vs. price of NT$22.90 (1.8% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Applied BioCode Business Description

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score

Get the complete analysis for TPE:6598

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.90
Price
NT$23.33
GF Value